The U.S. home infusion therapy market size is expected to reach USD 17.8 billion by 2026, registering a CAGR of 4.9% during the forecast period. The rising geriatric population and prevalence of health conditions such as cancer, immune deficiencies, Crohn’s disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, and gastrointestinal diseases are driving the demand for home infusion therapy in the country.
Growing cases of Hospital Acquired Infections (HAI) is another major driver for the U.S. market for home infusion therapy. According to the US Center for Disease Control and Prevention (CDC), annually, approximately 1.7 million admitted patients are affected by Health Care-associated infections (HCAI), and around 98,000 patients-one in every 17 patients- die due to HCAIs. This factor is anticipated to substantially drive the demand for home infusion therapy.
Increasing innovations in home infusion therapy such as the incorporation of Electronic Healthcare Records (EHR) along with medical devices and infusion pumps are expected to further fuel the market in the forthcoming years. The EHRs allow storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track improvements in the particular health condition.
U.S. Home Infusion Therapy Market Report Highlights
-
On the basis of product, Infusion pumps segment held the largest market share in 2018, due to increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids.
-
The needleless connectors segment is anticipated to lead the product segment with the fastest CAGR over the forecast period.
-
On the basis of application, the anti-infective application segment held the maximum share of the U.S. home infusion therapy market in 2018 owing to extensive use as antifungal, antibiotics, and antiviral agents at-home care.
-
The endocrinology application segment is projected to register the fastest CAGR over the forecast period, owing to a growing number of conditions associated with the endocrine system, such as thyroid and diabetes.
-
In April 2020, B. Braun Medical Inc. announced that it has received emergency use authorization from the US Food and Drug Administration (FDA) for the use of infusion pumps with nebulizers to treat COVID-19 patients.
“Would you Like/Try a Sample Report” Click the link below:https://www.grandviewresearch.com/industry-analysis/us-home-infusion-therapy-market/request/rs1
U.S. Home Infusion Therapy Market Segmentation
Grand View Research has segmented the U.S. home infusion therapy market based on product and application:
U.S. Home Infusion Therapy Product Outlook (Revenue, USD Million, 2014 – 2026)
-
Infusion Pumps
-
Ambulatory Infusion Pumps
-
Insulin Pumps
-
Syringe Pumps
-
Elastomeric Pumps
-
Patient Controlled Analgesics (PCA)
-
Volumetric Pumps
-
Intravenous Sets
-
IV Cannulas
-
Needleless Connectors
U.S. Home Infusion Therapy Application Outlook (Revenue, USD Million, 2014 – 2026)
-
Anti-Infective
-
Diabetes
-
Others
-
Endocrinology
-
Hydration Therapy
-
Athletes
-
Others
-
Chemotherapy
-
Enteral Nutrition
-
Parenteral Nutrition
-
Specialty Pharmaceuticals
-
Others
Key Players in the U.S. Home Infusion Therapy Market
-
B. Braun Melsungen
-
Baxter International
-
Caesarea Medical Electronics Ltd.
-
CareFusion
-
Fresenius Kabi
-
ICU Medical
-
JMS CO., LTD.
-
Smiths Medical, Inc.
-
Terumo Corporation
-
Coram LLC
-
Option Care Enterprises, Inc.
-
BioScrip, Inc.
-
BriovaRx Infusion Services
-
Paragon Healthcare.
Have Any Query? Ask Our Experts for More Details on Report:https://www.grandviewresearch.com/inquiry/6702/ibb
Browse Related Report @
Home Infusion Therapy Market – https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide.
Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/us-home-infusion-therapy-market